Home
Search
BIO International Convention   |   June 16-19, 2025

Speakers & Presenters

All Speakers
By Count|Alphabetical
  • Show All
By Count|Alphabetical
  • Show All
By Count|Alphabetical
  • Show All
Company Type
  • Show All
Main Therapeutic Focus
  • Show All
Development Phase of Primary Product
  • Show All
Search Speakers
All Speakers
Filter by letter
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Results
Ginger Hsiao
CIO, GOLD NEST CAPITAL
Data on the Economics of Investing in Early-Stage Life Science Opportunities
Singapore, Singapore
John Hsu, MD
CEO, QUIVIVEPHARMA.COM
Quivivepharma inc
Rowland Heights, California, United States
Chun-Hao Huang, PhD
CEO & CO-FOUNDER, ALGEN BIOTECHNOLOGIES
Algen Biotechnologies
San Francisco, United States
Michel Hubert, PharmD
VP CORPORATE DEVELOPMENT, OXYMO TECHNOLOGIES INC.
Oxymo Technologies Inc.
Versailles, France
Matthew Hudes
FOUNDER & CEO, BDLBIOLOGX
Platforms & Products: Creating Collaborations That Turn Technologies into Therapeutics
Los Gatos, California, United States
Nadia Huffman
PROJECT MANAGER, HARVARD KENNEDY SCHOOL HEALTH INEQUALITY LAB
Preparedness and Treatment Equity Coalition Informing System Reform to Improve Health Outcomes and Health Equity
Richard Hughes
PARTNER, EPSTEIN BECKER GREEN
The Future of the Vaccine Safety Net: Ensuring Equity, Access, Innovation, and the Business of Vaccines
Sasha Huhalov
SEARCH AND EVALUATION LEAD, TAKEDA PHARMACEUTICAL COMPANY
How to Strike a Deal in Oncology: Innovative Partnering Approaches Across Biotech and Pharma
Cambridge, Massachusetts, United States
Azer Hussain, PhD
HEAD OF QUANTITATIVE PHARMACOLOGY AND PHARMACOMETRICS – IMMUNO/ONCOLOGY, MERCK
Dose Optimization in Oncology: How Do We Tackle the Tricky Topic of Combinations?
Kyle Hvidsten
VICE PRESIDENT, HEAD OF GLOBAL HEALTH ECONOMICS AND VALUE, SANOFI
Determining Value: A Biotech Industry Discussion on Value Assessments and Alternative Proposals